© Copyright 2025 American Medical Association. All rights reserved.
Short Descr | ADM SARSCOV2 100MCG/0.5ML1ST | Medium Descr | IMM ADMN SARSCOV2 100 MCG/0.5 ML 1ST DOSE | Long Descr | Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; first dose | Status Code | Not Valid for Medicare Purposes | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Non-Covered Service, not paid under OPPS | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. |
Date
|
Action
|
Notes
|
---|---|---|
2025-01-01 | Deleted | First appearance of code deletion in codebook. |
2024-01-01 | Note | First appearance of 2022 AMA guideline changes in codebook. |
2023-11-01 | Deleted | Code deleted. To report administration of COVID-19 vaccine, use 90480. |
2023-04-18 | Note | Changes made to dosing information |
2023-04-18 | Note | These codes (associated with 0011A) are no longer authorized for use in the United States: 0012A, 0013A, 91301, 91306 91309, 91311. |
2023-04-18 | Note | No longer authorized for use in the United States. |
2023-01-01 | Note | First appearance of guideline change(s) in codebook. |
2022-12-08 | Note | AMA Guideline changed. 91316 received FDA approval. |
2022-11-16 | Note | AMA guideline changed to include 91316 effective upon receiving Emergency Use Authorization or approval from the FDA. |
2022-10-12 | Note | AMA Guideline changed. 91313 (12-17 yrs) received FDA approval. |
2022-10-12 | Note | AMA Guideline changed. 91314 received FDA approval. |
2022-08-31 | Note | AMA guideline changed to include 91314 effective upon receiving emergency Use Authorization or approval from the FDA. |
2022-08-31 | Note | AMA Guideline changed to include 91313 (18 yrs and older). and received FDA approval effective immediately. |
2022-08-31 | Note | Changes made to vaccine name, product & dosing information, & patient age to (12+). |
2022-06-17 | Note | AMA Guideline changed. 91311 received approval. |
2022-05-19 | Note | AMA guideline changed to include 91311 effective upon receiving Emergency Use Authorization or approval from the FDA |
2022-03-29 | Note | AMA Guideline changed. 91309 received FDA approval. |
2022-03-07 | Note | AMA guideline changed to include 91309 effective upon receiving Emergency Use Authorization or approval from the FDA |
2022-01-01 | Added | First appearance of code in codebook. |
2022-01-01 | Changed | Code description changed. |
2021-10-20 | Note | AMA Guideline changed. 91306 received FDA approval. |
2021-09-03 | Note | AMA guideline added and includes 91306 effective upon receiving Emergency Use Authorization or approval from the FDA |
2021-08-12 | Note | AMA guideline changed to include 0013A, 2021-08-16. FDA approval received. Effective retroactively to 2021-08-12 |
2021-01-01 | Added | First appearance of code in CPT® Code Set. |
2020-12-18 | Note | AMA Guideline changed. 0012A, 91301 received FDA approval. |
2020-12-18 | Added | FDA authorization granted |
2020-11-10 | Added | Published on AMA website. Effective upon receiving emergency Use Authorization or approval from the FDA. |
2020-11-10 | Note | AMA guideline published on website. Codes 91301, 0012A Effective upon receiving mergency Use Authorization or approval from the FDA. |
Get instant expert-level medical coding assistance.